Literature DB >> 38881

Translocation of cytosol protein kinase into nuclei and the induction of tyrosine hydroxylase in NBD-2 neuroblastoma cells.

R A Hollenbeck, D M Chuang, E Costa.   

Abstract

Exposure of neuroblastoma cells (NBD-2) to 8-bromo-adenosine 3',5'-cyclic monophosphate (0.2-1.0 mM) (8-Br-cAMP) for 15 min caused a long term increase in the Vmax of tyrosine-3-monooxygenase activity (TH) beginning about 1 day after 8-Br-cAMP application. Cyclic AMP-dependent histone kinase was maximally activated in about 30 min and stayed activated above pretreatment levels for one hour. In cells exposed to 8-Br-cAMP for 15 min, separation of soluble and particle bound histone kinase showed that the total histone kinase activity in the soluble fraction decreased by 40%. This decrease was accompanied by an increase in protein kinase activity in the particulate fraction, suggesting enzyme translocation. After translocation, the enzyme appears to acquire a different substrate affinity because it prefers as a PO43- acceptor, acidic protein rather than histone. In NBD-2 cells this kinase appears to precede, and may be related to, the delayed increase in TH Vmax.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 38881     DOI: 10.1016/0006-8993(79)91052-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Mutants of PC12 cells with altered cyclic AMP responses.

Authors:  T Block; C Kon; B M Breckenridge
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

Review 2.  [Nerve cell clonal lines in culture--models for studying the molecular basis of neuropharmacological actions].

Authors:  H Herken
Journal:  Klin Wochenschr       Date:  1983-01-03

3.  Direct cytochemical localization of catalytic subunits dissociated from cAMP-dependent protein kinase in Reuber H-35 hepatoma cells. II. Temporal and spatial kinetics.

Authors:  C V Byus; W H Fletcher
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.